Science and Enterprise

Category: New products

  • Heart Vessel Surgical Glue Shown Effective in Animal Tests

    Surgeons and biomedical engineers at Boston Children’s and Brigham and Women’s hospitals and Massachusetts Institute of Technology, developed a non-toxic, biocompatible surgical glue that in tests with pigs patches heart defects, such as those in large blood vessels. The team led by Boston Children’s Pedro del Nido and Jeffrey Karp of Brigham and Women’s Hospital…

  • Stem Cell Therapy Aids Patient with ALS, Myasthenia Gravis

    BrainStorm Cell Therapeutics Inc., in New York and Israel, reports a patient with the neurodegenerative diseases amyotrophic lateral sclerosis (ALS) and myasthenia gravis responded with improved motor and cognitive functions after stem cell treatments developed by the company. Researchers from Israeli medical centers and research institutes, and the Mayo Clinic in the U.S. report the…

  • Patch Finds More Heart Rhythm Problems Than Holter Monitor

    Researchers at Scripps Translational Science Institute in La Jolla, California found a small adhesive patch worn over the heart outperformed the conventional Holter monitor in detecting abnormal heart rhythms. The team led by Scripps cardiologist Eric Topol published its findings online in this month’s issue of the American Journal of Medicine. Topol and colleagues tested…

  • MRI Technique Developed to Capture Wrist Anatomy in Motion

    Medical researchers at University of California in Davis designed a technique based on magnetic resonance imaging (MRI) that makes it possible to display the complex anatomy of the wrist in motion, offering a better method for diagnosing orthopedic injuries. A team led by Davis radiology professor Abhijit Chaudhari published the results of its first test…

  • Imaging Technique Captures RNA Viral Infections in Progress

    Researchers at Georgia Institute of Technology and Emory University in Atlanta, and Vanderbilt University in Nashville devised a method with advanced microscopy to follow the process of viral infections without affecting the virus or its host. The team led by Georgia Tech biomedical engineering professor Philip Santangelo appeared online yesterday in the journal ACS Nano…

  • Genetic Mechanism to Increase Tomato Production Explained

    Biologists at Cold Spring Harbor Laboratory in New York discovered a genetic process underlying a breeding practice that helps improve yields of tomatoes. The Cold Spring Harbor team led by plant biology professor Zach Lippman, with a colleague from Monash University in Australia, published its findings yesterday in the journal PLoS Genetics. The team’s research…

  • Bacterial Bioflims Found Surviving on Children’s Toys

    Researchers at University at Buffalo in New York found bacteria associated with strep throat and ear infections to survive outside the body for long periods on toys at a day care center. The team of Buffalo microbiologist Anders Hakansson and doctoral candidates Laura Marks and Ryan Reddinger published their findings today online in the journal…

  • Large Genomic Study Finds New Rheumatoid Arthritis Targets

    An international consortium of 70 institutions and companies combined genome-wide analyses with current drug databases to uncover new genomic targets for rheumatoid arthritis, and identify drugs for other diseases with the potential to treat the disorder. The team led by Robert Plenge of Harvard Medical School and the Broad Institute and Yukinori Okada from the…

  • Discovery Process Devised to Better Test Drug Effects

    Biomedical researchers at Scripps Research Institute in La Jolla, California developed a drug discovery method that combines the rapid screening of potential compounds with preclinical tests of the best prospects, and in the process identified a potential new compound to treat type 2 diabetes. The Scripps team led by chemical physiologists Enrique Saez and Benjamin…

  • Drug Fixes Vision Birth Defect in Lab Tests, Trial Planned

    Medical researchers at University of British Columbia in Vancouver, Canada adapted a new drug as a treatment for aniridia, a rare eye disease caused by a birth defect, with tests on mice showing the drug’s potential effectiveness in treating the disorder. The team from UBC and the affiliated Vancouver Coastal Health, led by UBC ophthalmology…